open access
Primary diffuse large B-cell lymphoma of the uterine cervix — case report
open access
Abstract
We present a case of a 54-year-old woman treated for stage IIAE primary diffuse large B-cell lymphoma (DLBCL) of the uterine cervix. The CHOP chemotherapy regimen was started. After the diagnosis of lymphoma of DLBCL CD20+ type was confirmed, rituximab was added to the therapy. Within systemic therapy, the patient received two cycles of CHOP and six cycles of R-CHOP altogether. After treatment completion, total remission of the lesions was observed on computed tomography. Twenty-four months after therapy completion, the patient is disease-free with no signs of recurrence.
Abstract
We present a case of a 54-year-old woman treated for stage IIAE primary diffuse large B-cell lymphoma (DLBCL) of the uterine cervix. The CHOP chemotherapy regimen was started. After the diagnosis of lymphoma of DLBCL CD20+ type was confirmed, rituximab was added to the therapy. Within systemic therapy, the patient received two cycles of CHOP and six cycles of R-CHOP altogether. After treatment completion, total remission of the lesions was observed on computed tomography. Twenty-four months after therapy completion, the patient is disease-free with no signs of recurrence.
Keywords
chemotherapy; diffuse large B-cell lymphoma; uterine cervix
About this articleTitle
Primary diffuse large B-cell lymphoma of the uterine cervix — case report
Journal
Issue
Pages
318-320
Published online
2016-05-23
Page views
1031
Article views/downloads
2234
DOI
10.17772/gp/62355
Pubmed
Bibliographic record
Ginekol Pol 2016;87(4):318-320.
Keywords
chemotherapy
diffuse large B-cell lymphoma
uterine cervix
Authors
Zbigniew J. Kojs
Maciej Niemiec
Barbara Papuga-Fujak
Ewelina Kojs-Pasińska
Włodzimierz Sawicki
